Endo Int'l (ENDP) Closes Par Pharma Acquisition; Updates Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Endo Int'l (ENDP) Closes Par Pharma Acquisition; Updates Guidance

RBC Capital Cuts Price Target on Endo Int'l (ENDP) Following Guidance Update

September 29, 2015 7:42 AM EDT

RBC Capital maintained a Top Pick rating on Endo International plc (NASDAQ: ENDP), and cut the price target to $100.00 (from $107.00), following a guidance update. ENDP pointed to a 3Q range of $720-740 million in revenue which is 4% below consensus at the midpoint.

Analyst... More

Guggenheim Reiterates Buy on Endo Int'l (ENDP) Following Updated Guidance

September 28, 2015 11:24 AM EDT

Guggenheim reiterated a Buy rating and $110.00 price target on Endo International plc (NASDAQ: ENDP) following the company's updated financial guidance. Analyst Louise Chen continues to believe ENDP has set the stage for better-than-expected growth in '16+ driven by Xiaflex, Belbuca and the generics... More